Nephrology 

Nephrology Fellowship Photo

Fellowship ProgramNephrology


The Nephrology Fellowship Program at the University of Texas Medical Branch in Galveston is a fully accredited ACGME training program. We accept candidates who have completed three years of residency training in Internal Medicine. Our goal is to train fellows to provide compassionate care to patients with a variety of kidney diseases and to mold them into becoming clinician educators in the future. The Nephrology fellowship program consists of two years of training. The first year emphasizes clinical training through consult service rotations at the Jennie Sealy Hospital and the Texas Department of Criminal Justice (TDCJ) Hospital.

The second year is mostly devoted to elective rotations and completion of research activities. In the outpatient setting, the nephrology fellow has several continuity clinics devoted to the care of chronic kidney disease patients, kidney and pancreas transplant patients and home dialysis patients. The fellow also has exposure in caring for in-center hemodialysis patients through our division's partnership with DaVita

The strong emphasis on education is mirrored by our division's weekly conferences. Fellows and faculty have the opportunity to present the following:

  1. Core Curriculum Conference
  2. Physiology conference
  3. Case conference
  4. Clinical and Basic science journal club conference
  5. Nephrology Grand Rounds
  6. Renal pathology conference
  7. Transplant conference
  8. Research conference
  9. Home dialysis conference
  10. M&M conference
  11. Vascular access conference

A detailed conference schedule is found at the following links:

Assigned Days for conference
Fellows Conference Schedule

It is a program requirement for a fellow to have submitted a scholarly project (abstract, poster, case report, case series, manuscript, etc.) to a peer-reviewed journal upon the completion of his training. Basic science or translational research opportunities are also available in collaboration with various departments and divisions. 

Abstracts presented at national meetings over the past 3 years:

  1. Eltaweel, O, Elharrif, K, Kassem, H. Diffuse Alveolar Hemorrhage Treated with Plasma Exchange in Systemic lupus erythematosus Patient. Poster presentation at American College of Physicians meeting June 2019, Houston, TX.
  2. Omitogun T, Jacob S, Beach R, Elharrif, K A Case of Thin Basement Membrane Nephropathy with Focal Segmental Glomerulosclerosis and Heavy Proteinuria.. Poster presentation at NKF meeting 2019, Washington, DC.
  3. K Elharrif ,Y Lal, A Amin ,N Alhosainat, A Gamilla-Crudo, S Hussain, K Gugliuzza , M Mujtaba. Transplant Kidney Outcomes in Patients with Thrombotic Microangiopathy, Switched To Co-Stimulation Blocking Agent (Belatacept). Poster presentation at NKF meeting 2019, Washington, DC.
  4. N Alhosainat, Y Lal, A Amin, K Elharrif, A Gamilla-Crudo, S Hussain, K Gugliuzza M Mujtaba. Deceased Donor Kidney Transplant from A2/A2B to B Recipients; Navigating through IgM challenge. Poster presentation at NKF meeting 2019, Washington, DC.
  5. M. Mujtaba, S. Hussain, A. Amin, N. Al-Hosainat, Y. Lal, K. Elharrif, A. Gamilla-Crudo. Impact of Kidney Disease in Liver Transplant Rejection. Poster presentation at NKF meeting 2019, Washington, DC.
  6. Lal Y, Williams K, Afrouzian M, Amin A, Kassem H. Membranous glomerulopathy with monoclonal deposits, a case report with extended period of follow up. Poster presentation at NKF meeting 2019, Washington, DC.
  7. Schreiber B, Aleter O, Chaudhary V, Fischer W, Lal Y, Kassem H. Is it Time to Switch? Comparing transplant outcomes among dialysis modalities: Analysis from the United States Renal Data System (USRDS). Poster presentation at the American Society of Nephrology Kidney Week October 2018, San Diego, CA.
  8. Abifaraj F, Lal Y, Fischer W, Badalamenti J, Kassem H. Switching Dialysis Modalities for a Better Outcome: Analysis from the United States Renal Data System (USRDS). Poster presentation at the American Society of Nephrology Kidney Week October 2018, San Diego, CA.
  9. Lal Y, Kassem H, Ukudeyeva A, Charles D, Etienne S, Fischer W, Afrouzian M. Collapsing Glomerulopathy in Hepatitis C Virus Positive Patients: A Retrospective Autopsy Study of 95 Cases. Poster presentation at the American Society of Nephrology Kidney Week October 2018, San Diego, CA.
  10. Espinoza F, Afrouzian M, Omitogun T, Kassem H. Hepatitis B and C dual infection and collapsing glomerulopathy: Report of a rare association. Poster presentation at the American Society of Nephrology Kidney Week October 2018, San Diego, CA.
  11. Lal Y, Beach R, Recurrent Paraganlioma: Atypical presentation of a rare disorder. Accepted for Poster Presentation at the National Kidney Foundation Spring Clinical Meetings 2018; Austin, TX.
  12. Gamilla-Crudo A, Lal Y, Chaudhary V, Ramirez, R and Mujtaba, M. Preemptive Plasmapheresis for Prevention of Post-transplant FSGS Recurrence: UTMB Experience. Accepted for Poster Presentation at the National Kidney Foundation Spring Clinical Meetings 2018; Austin, TX.
  13. Chaudhary V, Lal Y, Chapman Y, Gamilla-Crudo A, Gugliuzza K, Hussain S and Mujtaba M. Do Organ Refusal Codes Really Matter? Accepted for Poster Presentation at the National Kidney Foundation Spring Clinical Meetings 2018; Austin, TX.
  14. Mujtaba M, Gamilla-Crudo A, Gugliuzza K, Aleter O, Shah S, Chapman Y, Reese J, Masood S, Taber T. Impact of Type 2 Surgical Injuries in Postmortem Donor Kidneys on the Post-Transplant Outcomes When Compared to Mate Non-Injured Kidney from the same donor. American Journal of Transplantation. 2017, Apr;17(S3): page663(411-485).
  15. Aleter O, Afrouzian M, Badalamenti J, Kassem H. Natural history of proliferative glomerulonephritis with monoclonal IgG deposits: a unique case with 3 renal biopsies obtained over 46 years of follow up. Poster presentation ASN Kidney Week, November 2017, New Orleans, LA.
  16. Noriega R, Kochar T, Kassem H, Ward A, Afrouzian M. Cryoglobulinemic glomerulonephritis in a patient with Sjogren Syndrome. Poster presentation ASN Kidney Week, November 2017, New Orleans, LA.
  17. Schreiber B, Espinoza F, Aleter O, Kassem H. Knowledge, attitude and practice of evaluation and management of mineral bone disease in chronic kidney disease amongst primary care physicians and nephrologists. Poster presentation ASN Kidney Week, November 2017, New Orleans, LA
  18. Mutnuri S, Kassem H, Afrouzian M. Lymphoma-associated monoclonal cryoglobulinemic GN in a patient with hepatitis C. Poster presentation ASN Kidney Week, November 2015, San Diego, CA
  19. Watts, III, B.A., T. George, E.R. Sherwood, and D.W. Good.  Monophosphoryl lipid A prevents sepsis-induced inhibition of HCO3- absorption in medullary thick ascending limb.  J. Am. Soc. Nephrol. 27: 367A, 2017.
  20. Shah S, Gamilla-Crudo A, Schreiber B, Espinoza F, Patankar R, Aleter O, Mujtaba M. Inter-correlations between Psychosocial Pre-transplant assessment as a determinant of Post-transplant kidney allograft function. Poster presented at the American Society of Nephrology Kidney Week 2017; New Orleans, LA, USA.
  21. Treatment of Post-Transplant De Novo HLA Donor Specific Antibodies in Kidney Transplant Recipient in the absence of rejection. Poster presented at 43rd Annual Meeting of the American Society for Histocompatibility and Immunogenetics, September 2017, San Francisco, CA, USA
  22. Schreiber B, Noriega R, Gamilla-Crudo A, Mujtaba M. Correlation of Pre-Kidney Transplant Psychosocial Factors with Post-Transplant Kidney Graft Survival. TH-PO979. JASN 2017: 28
  23. Patankar R, Chaudhary V, Shah S, Mujtaba M. Comparison between delayed graft function and slow graft function in predicting outcomes amongst kidney transplant recipients. TH-PO920. JASN 2017: 28.
  24. Espinoza F, Patankar R, Noriega R, Chaudhary V, Mujtaba M. Waist to Hip Ratio as a predictor of increased length of stay post kidney transplant. TH-PO997, JASN 2017: 28
  25. Schreiber B, Mujtaba M. Cytomegalovirus infection and hemophagocytic lymphohistiocytosis in a renal transplant patient. PUB745, JASN 2017; 28.
  26. Schreiber B, Mujtaba M. Atypical case of calciphylaxis in a renal transplant recipient. PUB590. JASN 2017: 28.
  27. Patankar R, Gamilla-Crudo A, Gugliuzza K, Salim O, Ikram F, and Mujtaba M. Early Outcomes of Kidney Transplantation When Comparing Waist-to-Hip Ratio vs. Body Mass Index. Am J Transplant. 2017; 17 (suppl 3).

 Manuscripts published in peer-reviewed journals over the past 3 years:

  1. Moinuddin, I., Yaqub, M. S., Taber, T., Mujtaba, M. and Sharfuddin, A.  Kidney Allograft Survival Outcomes in Combined Intestinal-Kidney Transplant: An Analysis of the UNOS/OPTN Database 2000-2014. Clin Transplant 2018 Jan 27. DOI 10.1111/ctr.13213.
  2. Watts, III, B.A., T. George, E.R. Sherwood, and D.W.Good.  Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.  Am J Physiol Renal Physiol. 313:F103-F115, 2017. doi: 10.1152/ajprenal.00064.2017.
  3. Foshat, M, Ruff M, Fischer W, Beach R, Fowler M, Ju H, Aronson J, Afrouzian M. Bile cast nephropathy in cirrhotic patients: effects of chronic hyperbilirubinemia. Am J Clin Pathol (2017) 147 (5): 525-535.
  4. Beach R. E.  My Approach to Patient with Hematuria.  ePrimary Care, May 2017.
  5. Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017 Jan;17(1):28-41.
  6. Liu YW, Mutnuri S, Siddiqui SB, Weikle GF, Oladipo O, Ganti N, Beach RE, and Afrouzian M..Levamisole-Adulterated Cocaine Nephrotoxicity: Ultrastructural Features. Am J Clin Pathol, May 2016;145:720-726.
  7. Deceased donor organ procurement injuries in the United States. Taber TE, Neidlinger NA, Mujtaba MA, Eidbo EE, Cauwels RL, Hannan EM, Miller JR, Paramesh AS. World J Transplant.2016 Jun 24;6(2):423-8. doi: 10.5500/wjt. v6.i2.423.
  8. Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared with Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis with Long-Term Follow-Up. Khalil A, Mujtaba MA, Aljanabi OT, Ghabril MS, Taber TE, Yaqub MS, Sharfuddin A. Exp Clin Transplant. 2016 Jun 15. doi: 10.6002/ect.2015.0296.
  9. Re-transplants compared to Primary Kidney Transplants Recipients: A Mate Kidney Paired analysis of the OPTN/UNOS database. Khalil AK, Mujtaba MA, Yaqub MS, Mishler DP, Taber TE, Sharfuddin AA. Clin Transplant. 2016 Feb 23. doi: 10.1111/ctr.12722.
  10. Effect of Treatment with Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients with End-Stage Renal Disease Awaiting Transplantation. Mujtaba MA, Komocsar WJ, Nantz E, Samaniego MD, Henson SL, Hague JA, Lobashevsky AL, Higgins NG, Czader M, Book BK, Anderson MD, Pescovitz MD, Taber TE.Am J Transplant. 2016 Jan 18. doi: 10.1111/ajt.13557.
  11. Watts, III, B.A., T. George, A. Badalamenti, and D.W. Good.  High mobility group box 1 inhibits HCO3- absorption in medullary thick ascending limb through RAGE-Rho-ROCK-mediated inhibition of basolateral Na+/H+ exchange.  Am. J. Physiol. Renal Physiol. 311: F600-F613, 2016.
  12. Good, D.W., T. George, and B.A. Watts, III.  High mobility group box 1 inhibits HCO3- absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.  Am. J. Physiol. Renal Physiol. 309: F720-F730, 2015.
  13. Beach R. E. My Approach to Chronic Kidney Disease. ePrimary Care, November 2015.
  14. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease. Jhawar S, Singh P, Torres D, Ramirez-Valle F, Kassem H, Banerjee T, Dolgalev I, Heguy A, Zavadil J, Lowenstein J. PLoS One. 2015 Mar 26;10(3).
  15. Trends and Outcomes in Right versus Left Living Donor Nephrectomy: An Analysis of the OPTN/UNOS Database of Donor and Recipient Outcomes. Should we be doing more Right Sided Nephrectomies? Khalil A, Mujtaba MA, Taber TE, Yaqub MS, Goggins W, Powelson J, Sundaram C, Sharfuddin AA. Clin Transplant. 2015 Nov 21. doi: 10.1111/ctr.12668.
  16. Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies. Mujtaba MA, Fridell J, Book B, Faiz S, Sharfuddin A, Wiebke E, Rigby M, Taber T. Clin Transplant. 2015 Nov;29(11):991-6. doi: 10.1111/ctr.12619.
  17. Early Fatal Cutaneous Lower Extremity Angiosarcoma Associated with Deep Venous Thrombosis in a Renal Transplant Recipient. Sher SJ, Mujtaba MA, Yaqub MS, Taber TE, Mishler DP, Sharfuddin AA. Exp Clin Transplant. 2015 Jul 2. doi:  0.6002/ect.2014.0289.
  18. Long Term Outcomes of Transplant Recipients Referred for Angiography for Suspected Transplant Renal Artery Stenosis. Ali A, Mishler D, Taber T, Agarwal D, Yaqub M, Mujtaba M, Goggins W, Sharfuddin A. Clin Transplant. 2015 Jun 5. doi: 0.1111/ctr.12574.
  19. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence. Mujtaba MA, Sharfuddin AA, Book BL, Goggins WC, Khalil AA, Mishler DP, Fridell JA, Yaqub MS, Taber TE. Clin Transplant. 2015 May 12. doi: 10.1111/ctr.12562.
  20. Impact of duration of diabetes on outcome following pancreas transplantation. Ekser B, Mangus RS, Powelson JA, Goble ML, Mujtaba MA, Taber TE, Fridell JA. Int J Surg. 2015 Apr 11; 18:21-27. doi: 10.1016/j.ijsu.2015.04.031.
  21. Fridell JA, Mangus RS, Chen JM, Goble ML, Mujtaba MA, Taber TE, Powelson JA. Late pancreas retransplantation. Clin Transplant. 2015 Jan; 29(1):1-8. doi: 10.1111/ctr.12468.
Current Fellows

Fellows

  • Alhosainat, Nidal, MBBS

    Alhosainat, Nidal, MBBS
    PGY 5

    Division: Nephrology
    Department: Internal Medicine
  • Amin, Aisha, MD

    Amin, Aisha, MBBS
    PGY 4

    Division: Nephrology
    Department: Internal Medicine
  • Elharrif, Khalid, MBChB

    Elharrif, Khalid, MBChB
    PGY 5

    Division: Nephrology
    Department: Internal Medicine
  • Hussein, Hussein, MBChB

    Hussein, Hussein, MBChB
    PGY 4

    Division: Nephrology
    Department: Internal Medicine
  • Rizvi, Asim, MBBS

    Rizvi, Asim, MBBS
    PGY 4

    Division: Nephrology
    Department: Internal Medicine

Previous Fellows

Fellow Graduates ABIM/Nephrology Board Certified Academic Position Private Practice State/Country
2018    
Chaudhary, VishyXX  
Lal, Yasir    
Noriega, Ramon  X 
Omitogun, Tunde    
     
2017    
Patankar, RohanNot Taken
XTexas
Wong, AdrianX XTexas
 
   
2016    
Hussain, SyedXX Texas
Moise, DianaUnknown XConnecticut
Mutnuri, Sangeeta
X XTexas
 
   
2015    
Bhandal, ManpreetXX Alaska
Walia, IshmeetX XTexas
 
   
2014    
Adari, SailajaXX
South Carolina
Saluja, ParamveerX XTexas
Sardar, AsjadXX Arizona
 
   
2013    
Baltodano, RicardoX
XTexas
 
   
2012    
Mastouri, Nasim X XOhio
Salameh, HasanX XUtah
Takkar, Chandandeep
X XTexas
Application Process

Our fellowship program is accredited by ACGME (http://acgme.org).

Our program participates in the NRMP (http://nrmp.org/) and all applications are submitted through ERAS (http://aamc.org/services/eras/). 

The program accepts U.S. citizens, permanent residents and J1 visa holders.  H1B visa holders are considered on a case by case basis. 

UTMB is an Equal Opportunity Employer and applications from women and members of minority groups are strongly encouraged.

For additional information, please contact:

Nephrology Fellowship Coordinator
Vicki Hudson
University of Texas Medical Branch
301 University Blvd.
Galveston, TX 77555-0570
Phone:  409-772-1756
Fax:  409-772-5462
Email:  vilhudso@utmb.edu

John Badalamenti, M.D.
Associate Professor of Medicine
Director, Nephrology Fellowship Program
Medical Director, Acute Dialysis Unit
Medical Director, Nephrology Clinic

Hania Kassem, M.D.
Assistant Professor
Assoc. Director, Nephrology Fellowship Program
Medical Director, Home Dialysis Program

 


 

Benefits (https://hr.utmb.edu/benefits/)

UTMB

  1. Competitive salary
  2. High quality health insurance for the fellow and family which includes dental, and disability insurance.Vision insurance available at a low cost to fellow.
  3. High level of employer contribution to 401K retirement package
  4. Employee Discount Programs
  5. Vacation – up to 12 days per year
  6. Sick Leave – up to 12 days per year
  7. Holidays – any holidays worked will accrue 8 hours holiday to use at a later date

Nephrology

  1. Moving Allowance up to $5000.00
  2. Parking – Paid by Nephrology
  3. Textbooks provided
  4. Travel support to one conference per year
  5. Personalized UTMB jackets

For additional information, please visit: https://www.utmb.edu/gme/